HYDROGEL FORMULATION COMPRISING ZEBULARINE AND RETIONIC ACID
A pharmaceutical composition comprising two hydrogel formulations with biologically active substances for simultaneous use, one mixture of which comprises not less than 60 and not more than 240 mg of zebularine added to 1 ml of sodium alginate hydrogel, and the other mixture of which comprises not less than 1 and not more than 4 mg of retinoic acid added to 1 ml of sodium alginate hydrogel, wherein the biologically active substances, i.e. zebularine and retinoic acid, release gradually from each formulation due to hydrogel biodegradation, which allows their combined action to be used to stimulate complex tissue regeneration..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SKOWRON PIOTR [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-06-21, Last update posted on www.tib.eu: 2023-07-18, Last updated: 2023-07-21 |
|---|
| Patentnummer: |
EP4197526 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017543509 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017543509 | ||
| 003 | DE-627 | ||
| 005 | 20230721103208.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230708s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017543509 | ||
| 035 | |a (EPA)EP4197526 | ||
| 035 | |a (EPA)85202121 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SKOWRON PIOTR |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HYDROGEL FORMULATION COMPRISING ZEBULARINE AND RETIONIC ACID |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-06-21, Last update posted on www.tib.eu: 2023-07-18, Last updated: 2023-07-21 | ||
| 520 | |a A pharmaceutical composition comprising two hydrogel formulations with biologically active substances for simultaneous use, one mixture of which comprises not less than 60 and not more than 240 mg of zebularine added to 1 ml of sodium alginate hydrogel, and the other mixture of which comprises not less than 1 and not more than 4 mg of retinoic acid added to 1 ml of sodium alginate hydrogel, wherein the biologically active substances, i.e. zebularine and retinoic acid, release gradually from each formulation due to hydrogel biodegradation, which allows their combined action to be used to stimulate complex tissue regeneration. | ||
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a RODZIEWICZ-MOTOWIDLO SYLWIA |4 aut | |
| 700 | 0 | |a DZIERZYNSKA MARIA |4 aut | |
| 700 | 0 | |a SAWICKA JUSTYNA |4 aut | |
| 700 | 0 | |a SACHADYN PAWEL |4 aut | |
| 700 | 0 | |a SLONIMSKA PAULINA |4 aut | |
| 700 | 0 | |a SOSNOWSKI PAWEL |4 aut | |
| 700 | 0 | |a SASS PIOTR |4 aut | |
| 700 | 0 | |a KAMINSKA JOLANTA |4 aut | |
| 700 | 0 | |a BACZYNSKI-KELLER JAKUB |4 aut | |
| 700 | 0 | |a PLATEK RAFAL |4 aut | |
| 700 | 0 | |a DEPTULA MILENA |4 aut | |
| 700 | 0 | |a PIKULA MICHAL |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 21. Juni |
| 773 | 1 | 8 | |g year:2023 |g day:21 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/85202121/publication/EP4197526A1?q=EP4197526 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 21 |c 06 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 21 |c 06 | ||